Petros Pharmaceuticals Inc. is ensuring that investors as well as other interested parties know about each point of progress in its program targeting launching the first erectile dysfunction drug available OTC in the US.
Two weeks after announcing strong results from a label comprehension study, it’s initiating a self-selection study using the Drug Facts...







